Seattle, Sept. 28, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights’ analysis, the global research antibodies market is estimated to be valued at US$ 3,574.6 Mn in 2022 and expected to exhibit a CAGR of 5.9% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Research Antibodies Market:
Key trends in market include increasing acquisitions, collaborations by market players, increasing product approvals, increasing partnerships and product launches by market players.
Increasing acquisitions, collaborations by market players is expected to drive growth of market over the forecast period. For instance, in July 2021, PerkinElmer Inc., an American global corporation focused in the business areas of diagnostics, life science research, acquired Biolegend, a global developer and manufacturer of antibodies and reagents used in biomedical research. The acquisition will allow BioLegend to expand PerkinElmer's present life science business into new markets.
Increasing product approval by U.S. Food and Drug Administration is a major contributing factor in the global research antibodies market growth over the forecast period. For instance, in December 2020, Amgen Inc., a U.S. based multinational biopharmaceutical company, announced that Riabnitm (rituximab-arrx), a biosimilar of Rituxan (rituximab), has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Non-Lymphoma Hodgkin's (NHL), Chronic Lymphocytic Leukemia (CLL).
Increasing partnerships and product launches by market players is expected to boost the growth of market over forecast period. For instance, in January 2022, Vir Biotechnology, U.S. based clinical-stage Immunology Company, partnered with Bill & Melinda Gates Foundation, non-profit foundation fighting poverty, disease, and inequity around the world and launched new antibody research initiative aimed at a functional cure for HIV and prevention of malaria. The new initiative entails a clinical proof-of-concept trial aimed at evaluating the potential effects of broadly neutralizing antibodies engineered to prevent viral replication and spread in HIV-positive individuals as well as their capacity to confer a vaccine-like effect that may be applicable to long-term antiretroviral therapy (ART)-free suppression of HIV.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/5247
Key Market Takeaways:
Increasing product approvals by the U.S. Food & Drug Administration (FDA) are expected to drive growth of the global research antibodies market. For instance, on May 31, 2022, the U.S. Food & Drug Administration (FDA) accepted Sanofi, a French multinational pharmaceutical and healthcare company’s Dupixent (dupilumab) for priority review in adults with prurigo nodularis. Prurigo nodularis is a chronic inflammatory skin disease that causes extreme itch and skin lesions. Dupixent is the first and only medication specifically designed to treat prurigo nodularis in the U.S.
Competitive Landscape:
Key players operating in the global research antibodies market include Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals, Abcam plc.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/5247
Market Segmentation:
- Global Research Antibodies Market, By Product Type:
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Consumables
- Global Research Antibodies Market, By Form:
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Global Research Antibodies Market, By Source:
- Mouse
- Rabbit
- Goat
- Others (Guinea Pigs, Rat etc.)
- Global Research Antibodies Market, By Application:
- Western Blotting
- ELISA
- Flow Cytometry
- Immunocytochemistry (ICC)/ Immunofluorescence (IF)
- Immunohistochemistry (IHC)
- Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
- Global Research Antibodies Market, By End User:
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Global Research Antibodies Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Country:
- North America
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
Related Market Intelligence Reports:
Cell Culture Market, by Product Type (Instruments and Consumables), by Application (Vaccine Production, Gene Therapy, Cancer Research, Tissue Culture, Drug Development, and Others), by End User (Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030
DNA Extraction Kits Market, By Product (Cell-free DNA, Genomic DNA, and Others), By Application (PCR, Sequencing, Cloning, and Others), By Sample Type (Blood, Tissue, & FFPE, Cells, and Others), By End-User (Healthcare Facilities, Research Institutes, Pharma & Biotech Companies, and Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
